Director Alethia Young resigns from PTC board, stays as consultant at $4,167/month

PTC THERAPEUTICS, INC.

Alethia Young resigned from the Board effective June 8, 2026; no disagreement cited.
She entered a consulting agreement through June 8, 2027 for monthly fee of $4,166.67.
Outstanding stock options and RSUs will continue to vest during consulting term.
Exercisability of options extends to three years after termination (max 10 years from grant).

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alethia Young

Member of the board of directors

PTCT · PTC THERAPEUTICS, INC.

Effective: 2026-06-08
Filed: June 9, 2026, 5:15 PM ET

On June 8, 2026, Alethia Young, a member of the board of directors (the "Board") of PTC Therapeutics, Inc. (the "Company"), notified the Company of her resignation from the Board effective June 8, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alethia Young resigned as Member of the board of directors at PTC THERAPEUTICS, INC..

Action: resigned
Role: Member of the board of directors

Exact text from the filing

On June 8, 2026, Alethia Young, a member of the board of directors (the "Board") of PTC Therapeutics, Inc. (the "Company"), notified the Company of her resignation from the Board effective June 8, 2026.

View on SEC.gov

PTC THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-26-071916

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.